J Liliemark Selected Research

Leukemia

5/2000

P-Glycoprotein inhibitor valspodar (PSC 833) increases the intracellular concentrations of daunorubicin in vivo in patients with P-glycoprotein-positive acute myeloid leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J Liliemark Research Topics

Disease

1	Neoplasms (Cancer) 01/2001
1	Hematologic Neoplasms (Hematological Malignancy) 01/2001
1	Leukopenia 01/2001
1	Leukemia 05/2000
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2000

Drug/Important Bio-Agent (IBA)

1	Etoposide (VP 16)FDA LinkGeneric 01/2001
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 05/2000
1	Daunorubicin (Cerubidine)FDA LinkGeneric 05/2000
1	valspodar (PSC 833)IBA 05/2000

Therapy/Procedure

1	Palliative Care (Palliative Therapy) 01/2001
1	Oral Administration 01/2001